1
/
of
0
FDA Drug Approval, N018895, TPN ELECTROLYTES IN PLASTIC CONTAINER
FDA Drug Approval, N018895, TPN ELECTROLYTES IN PLASTIC CONTAINER
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 018895
Company: HOSPIRA
Drug Name: TPN ELECTROLYTES IN PLASTIC CONTAINER
Active Ingredients: CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
Strength: 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML;16.1MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 07/20/1984
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: HOSPIRA
Drug Name: TPN ELECTROLYTES IN PLASTIC CONTAINER
Active Ingredients: CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
Strength: 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML;16.1MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 07/20/1984
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details